Print
Email
Print Edition StoriesFriday, February 26, 2010
PerkinElmer acquires partner's mass spectrometry unit
By Julie M. Donnelly
MHT's Julie Donnelly: Pharmaceuticals find drug development partners in colleges
MHT's Galen Moore: Honoring innovation in New England
MHT's Julie Donnelly: Life science startups finding investments
PerkinElmer has announced it has agreed to buy out Washington D.C.-based partner Danaher Corp.’s share of a joint venture in the mass spectrometry business, Inductively Coupled Plasma Mass Spectrometry (ICP-MS), originally part of Danaher’s acquisition of MDS Inc.’s Analytics Technologies business.
The move is designed to better the competitive position of the Waltham-based human and environmental health company, versus its competitors, which include local companies Bruker and Thermo Fisher Scientific.
Mass spectrometers are used in a number of health-related indications, including separating parts of substances to check for food, medication and drink safety. Mass spectrometry is also used in drug development.
John Roush, president of environmental health, PerkinElmer, touted the company’s newly bought out ICP-MS unit for providing analysis and solutions to toxic elements that pose potential safety threats.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
